Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Charlotte Druart
Long-Term Safety and Real-World Effectiveness of Fingolimod in Relapsing Multiple Sclerosis
Patient Related Outcome Measures
Related publications
The Real-World Effectiveness and Safety of Fingolimod in Relapsing-Remitting Multiple Sclerosis Patients: An Observational Study
PLoS ONE
Multidisciplinary
Efficacy of Natalizumab and Fingolimod in Relapsing Remitting Multiple Sclerosis in Real World Clinical Setting
Journal of Neurology & Neurophysiology
Long-Term Evaluation of NEDA-3 Status in Relapsing-Remitting Multiple Sclerosis Patients After Switching From Natalizumab to Fingolimod
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Long-Term Safety and Efficacy of Natalizumab in Relapsing-Remitting Multiple Sclerosis: Impact on Quality of Life
Patient Related Outcome Measures
Long-Term Effects of Fingolimod in Multiple Sclerosis: The Randomized FREEDOMS Extension Trial
Neurology
Neurology
Fingolimod and CSF Neurofilament Light Chain Levels in Relapsing-Remitting Multiple Sclerosis
Neurology
Neurology
Alemtuzumab in the Long-Term Treatment of Relapsing-Remitting Multiple Sclerosis: An Update on the Clinical Trial Evidence and Data From the Real World
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Real-Life Effectiveness of Natalizumab in Relapsing-Remitting Multiple Sclerosis (Rrms): A Registry Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Design of a Non-Interventional Post-Marketing Study to Assess the Long-Term Safety and Effectiveness of Ocrelizumab in German Real World Multiple Sclerosis Cohorts – The CONFIDENCE Study Protocol
BMC Neurology
Medicine
Neurology
